Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr R Neely.

Newcastle AuthorsTitleYearFull text
Dr R Neely
Lp(A): When and how to measure it2021
Dr R Neely
Corrigendum to “HEART UK consensus statement on Lipoprotein(a): A call to action” [Atherosclerosis 291 (2019) 62–70]2020
Dr Danny Chan
Dr Carmen Martin-Ruiz
Dr Gabriele Saretzki
Dr R Neely
Dr Vijay Kunadian
et al.
The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome2020
Dr R Neely
The clinical and laboratory investigation of dysbetalipoproteinemia2020
Dr R Neely
Evaluation of the non-HDL cholesterol to apolipoprotein B ratio as a screening test for dysbetalipoproteinemia2019
Dr R Neely
HEART UK consensus statement on Lipoprotein(a): A call to action2019
Dr David Woods
Dr R Neely
Dr Katherine Talks
Dr Alison Heggie
Dr Richard Quinton
et al.
Hematopoiesis Shows Closer Correlation with Calculated Free Testosterone in Men than Total Testosterone2017
Emeritus Professor Margaret Bassendine
Dr Soren Nielsen
Dr Simon Bridge
Dr Daniel Felmlee
Dr David Sheridan
et al.
Hepatitis C virus and atherosclerosis: A legacy after virologic cure?2017
Dr Vijay Kunadian
Dr R Neely
Dr Hannah Sinclair
Dr Jonathan Batty
Dr Murugu Veerasamy
et al.
A Study to Improve Cardiovascular Outcomes in High-Risk Older PatieNts (ICON-1) with Acute Coronary Syndrome: Study Design and Protocol of a Prospective Observational Study2016
Dr Jonathan Batty
Dr R Neely
Dr Vijay Kunadian
PCSK9 inhibitors in the prevention of cardiovascular disease2016
Anna Long
Dr Sarah Johnson
Dr R Neely
Dr David Richardson
Dr James Graham
et al.
Phaeochromocytoma and ACTH-dependent cushing's syndrome: tumour crf secretion can mimic pituitary cushing's disease2016
Dr Iftikhar Fazal
Dr R Neely
Dr Guy MacGowan
Dr Jane Skinner
Impact of using different guideline recommended serum natriuretic peptide thresholds on the diagnosis and referral rates of a diagnostic heart failure clinic2015
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Fiona Fenwick
Dr Clare Lanyon
et al.
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism2015
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Dr R Neely
Emeritus Professor Margaret Bassendine
et al.
Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency2014
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Fiona Fenwick
Dr R Neely
et al.
Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial2014
Dr R Neely
The importance of early diagnosis: How to identify patients with FH for diagnosis and referral2014
Dr R Neely
Richard Bliss
Dr Stephen Ball
A 12 cm mass with no symptoms and unremarkable laboratory results2013
Dr David Sheridan
Dr R Neely
Professor Margaret Bassendine
Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)2013
Professor Margaret Bassendine
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Dr R Neely
et al.
Lipids and HCV2013
Dr R Neely
Agarose Electrophoresis Assay for the Quantitative Determination of Lipoprotein-X Using Novel Enzymatic Staining for Total and Free Cholesterol2012
Dr Ana Jovanovic
Dr R Neely
An eggstreme diet; the effect of egg intake on the lipid profile2012
Dr Jonathan Wallis
Dr R Neely
An unusual case of secondary hyperlipidaemia2012
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Professor Geoff Toms
Dr R Neely
et al.
Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity2012
Professor Margaret Bassendine
Dr David Sheridan
Dr Daniel Felmlee
Dr Simon Bridge
Professor Geoff Toms
et al.
HCV and the hepatic lipid pathway as a potential treatment target2011
Dr R Neely
Professor Margaret Bassendine
Antisense technology to lower LDL cholesterol2010
Dr Latika Sibal
Dr R Neely
Emeritus Professor Philip Home
Friedewald equation underestimates low-density lipoprotein cholesterol at low concentrations in young people with and without Type 1 diabetes2010
Dr David Sheridan
Professor Kim Bartlett
Dr Daniel Felmlee
Dr Simon Bridge
Professor Geoff Toms
et al.
Hypocholesterolaemia in chronic Hepatitis C virus (HCV) infection - Reduced production or increased LDL clearance?2010
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Dr Soren Nielsen
Dr R Neely
et al.
Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection2010
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Dr Soren Nielsen
Dr R Neely
et al.
Insulin resistance correlates with low density hepatitis C virus particles in genotype 1 infection2010
Dr Daniel Felmlee
Dr David Sheridan
Dr Simon Bridge
Dr Soren Nielsen
Professor Geoff Toms
et al.
Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles2010
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Professor Geoff Toms
Dr R Neely
et al.
Low density Hepatitis C virus particles (lipoviral particles) associate with insulin resistance in genotype 1 infection2010
Dr David Sheridan
Dr David Price
Dr Matthias Schmid
Professor Geoff Toms
Dr Peter Donaldson
et al.
Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin2009
Dr R Neely
Lipid external quality assessment: commutability between external quality assessment and clinical specimens2008
Dr Harish Datta
Dr R Neely
Hepatic surgery-related hypophosphatemia2007
Dr R Neely
Provision of laboratory services for lipid analysis in the United Kingdom2007
Dr R Neely
Dr Richard Quinton
Complete reversal of adult-onset isolated hypogonadotropic hypogonadism with clomiphene citrate2006
Dr Stephen Ball
Dr Richard Quinton
Dr Robert James
Professor Simon Pearce
Professor Thomas Lennard
et al.
Detection of phaeochromocytoma: The emerging role of plasma metanephrines2006
Dr Richard Quinton
Dr R Neely
The investigation and management of critical hyponatraemia2006
Dr R Neely
Biochemical diagnosis of phaeochromocytoma: The role of plasma metadrenalines2005
Dr R Neely
Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate2005
Dr Balasubramanian Ravikumar
Dr Peter Carey
Dr David Cook
Dr R Neely
Dr Michael Firbank
et al.
Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes2005
Dr Chankramath Arun
Dr Harish Datta
Dr R Neely
Response to atorvastatin in a case of idiopathic hypoalbuminaemia complicated by remnant hyperlipidaemia2005
Dr R Neely
Is coenzyme Q10 supplementation beneficial in patients with statin associated muscle symptoms and normal creatine kinase levels?2004
Dr R Neely
Beyond cholesterol - HEART UK survey of analytical services available to UK lipid clinics2003
Dr Michael Laker
Dr R Neely
The investigation and management of dyslipidaemia: An update2003